Aracari Biosciences
Aracari Biosciences is dedicated to accelerating drug development by utilizing proprietary microphysiological platforms that mimic human tissues. Their platforms incorporate living, perfused human vasculature to deliver nutrients, drugs, and immune cells, providing more physiologically relevant data for drug screening and disease modeling. They focus on vascularized micro-organ and micro-tumor systems to better predict efficacy and safety of therapeutics, especially in immuno-oncology and other fields.
Industries
Nr. of Employees
small (1-50)
Products
Vascularized organ microphysiological platform
A microfluidic platform that generates perfused, vascularized micro-organs for studying tissue physiology, nutrient/drug delivery, and vascular responses in vitro.
Vascularized tumor microphysiological platform
Array-compatible tumor-on-chip platform supporting vascularized tumor growth and drug response measurements for multiple tumor types.
Vascularized brain/blood–brain barrier microphysiological platform
3D microphysiological constructs modeling the neurovascular interface for studying BBB permeability and CNS-targeted delivery.
Vascularized organ microphysiological platform
A microfluidic platform that generates perfused, vascularized micro-organs for studying tissue physiology, nutrient/drug delivery, and vascular responses in vitro.
Vascularized tumor microphysiological platform
Array-compatible tumor-on-chip platform supporting vascularized tumor growth and drug response measurements for multiple tumor types.
Vascularized brain/blood–brain barrier microphysiological platform
3D microphysiological constructs modeling the neurovascular interface for studying BBB permeability and CNS-targeted delivery.
Services
Contract studies using vascularized 3D tumor microtissues to evaluate tumor growth, drug efficacy, tumor–stroma interactions, and vascular responses.
Assays to measure immune cell adhesion, extravasation, migration, tumor occupancy, and tumor killing by various T cell populations within vascularized microtissues.
3D BBB-on-chip studies to evaluate trafficking across the neurovascular interface and model CNS-relevant pathologies and permeability.
Testing for vessel toxicity, vasoactivity (vasoconstriction/vasodilation), anti-angiogenic effects, and vessel stabilization using vasoreactive vascularized micro-organ constructs.
Contract studies using vascularized 3D tumor microtissues to evaluate tumor growth, drug efficacy, tumor–stroma interactions, and vascular responses.
Assays to measure immune cell adhesion, extravasation, migration, tumor occupancy, and tumor killing by various T cell populations within vascularized microtissues.
3D BBB-on-chip studies to evaluate trafficking across the neurovascular interface and model CNS-relevant pathologies and permeability.
Testing for vessel toxicity, vasoactivity (vasoconstriction/vasodilation), anti-angiogenic effects, and vessel stabilization using vasoreactive vascularized micro-organ constructs.
Expertise Areas
- Microphysiological systems development
- Tumor-on-chip and tumor microenvironment modeling
- Vascular biology and vasoreactivity testing
- Immuno-oncology functional assays
Key Technologies
- Microfluidics
- Perfusable microvasculature in 3D tissues
- Hydrostatic (gravity-driven) flow control
- Arrayed 96-well microtissue platforms